|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S1
|
$48,687
|
$2,434
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S2
|
$85,299
|
$4,265
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S3
|
$47,040
|
$2,352
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
5U54CA163071-07
|
$1,619,382
|
$80,969
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
5U54CA163068-07
|
$1,751,252
|
$87,563
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5U01CA164974-08
|
$3,131,894
|
$313,189
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
|
5R01CA175318-04
|
$354,563
|
$354,563
|
HATEFI, ARASH
|
RUTGERS, THE STATE UNIV OF N.J.
|
|
|
A network platform to connect drug response and prognosis phenotypes for cancers
|
5R01CA196631-03
|
$395,911
|
$197,956
|
LI, HU
|
MAYO CLINIC ROCHESTER
|
|
|
A New Ovarian Cancer Mouse Model Based on Nanoparticle Gene Delivery
|
5R03CA216127-02
|
$83,750
|
$83,750
|
YANG, YANG
|
YALE UNIVERSITY
|
|
|
A novel more effective genotoxic therapy for ovarian cancer
|
1R37CA215436-01A1
|
$368,288
|
$368,288
|
SIMPKINS, FIONA
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
A Systems Biology Approach to Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
|
5F30CA213737-02
|
$44,724
|
$44,724
|
MCGEHEE, CORDELIA
|
MAYO CLINIC ROCHESTER
|
|
|
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display
|
5R21CA204708-02
|
$191,186
|
$95,593
|
MALMSTADT, NOAH
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$477,453
|
$23,873
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S1
|
$244,519
|
$4,890
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S2
|
$55,717
|
$1,114
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S3
|
$65,235
|
$1,305
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-42
|
$7,716,753
|
$154,335
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$125,971
|
$12,597
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
|
Activating Cell Death Pathways in Breast Cancer Cells
|
ZIA SC 007263
|
$469,702
|
$46,970
|
Lipkowitz, Stanley
|
CCR (NCI)
|
|
|
Administrative Supplement to Cancer Center Support Grant to Support Acquisition and Annotation of Biospecimens
|
3P30CA022453-36S5
|
$46,200
|
$462
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
|
Ambient dioxin exposure and cancer risk in women (IWHS and AHS)
|
ZIA CP010125 10712
|
$40,865
|
$4,087
|
Jones, Rena
|
DCEG (NCI)
|
|
|
An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer
|
5R01CA182832-05
|
$323,695
|
$323,695
|
MATEI, DANIELA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
Analysis of BRCA Testing Patterns Using the Utah Population Database
|
5R03CA212911-02
|
$76,250
|
$38,125
|
KOHLMANN, WENDY
|
UNIVERSITY OF UTAH
|
|
|
Analysis of BRCA1 Recombination Functions
|
5R01CA095175-14
|
$328,700
|
$164,350
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
|
5R01CA181543-05
|
$394,740
|
$394,740
|
BRUGGE, JOAN
|
HARVARD MEDICAL SCHOOL
|
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$30,758
|
Barr, Frederic
|
CCR (NCI)
|
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AID
|
ZIA SC 004020
|
$3,223,418
|
$322,342
|
Berzofsky, Jay
|
CCR (NCI)
|
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-08
|
$380,000
|
$380,000
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Assessment of Screening Modalities for Gynecologic Cancers
|
ZIA CP010126 10495
|
$49,257
|
$24,629
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
|
Assistant Director Flow and Image Cytometry Roswell Park Cancer Institute
|
5R50CA211108-03
|
$250,131
|
$125,066
|
MINDERMAN, HANS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Averting recurrent and resistant ovarian tumors
|
5R01CA211175-02
|
$451,109
|
$451,109
|
WANG, QIEN
|
OHIO STATE UNIVERSITY
|
|
|
B cell-dependent anti-tumor immunity in ovarian cancer
|
1U01CA232758-01
|
$781,585
|
$781,585
|
CONEJO-GARCIA, JOSE
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$2,378
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$5,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$64,062
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
BCDDP: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182 01030
|
$6,159
|
$1,232
|
Schairer, Catherine
|
DCEG (NCI)
|
|
|
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
|
5R01CA193249-03
|
$603,615
|
$603,615
|
LUTGENDORF, SUSAN
|
UNIVERSITY OF IOWA
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$753,084
|
$37,654
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Biomedical Applications of Expanded Porphyrins: Development of Gold-Texaphyrin Conjugates
|
5R01CA068682-26
|
$360,416
|
$360,416
|
SESSLER, JONATHAN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
|
Blocking NK cell shedding of CD16a to increase cancer cell killing
|
5R01CA203348-03
|
$447,909
|
$447,909
|
WALCHECK, BRUCE
|
UNIVERSITY OF MINNESOTA
|
|
|
BRCA Challenge Tools
|
ZIH CP010205 10746
|
$43,606
|
$10,901
|
Hoover, Robert
|
DCEG (NCI)
|
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
3R01CA136512-08S1
|
$73,692
|
$36,846
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INST
|
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
5R01CA136512-08
|
$515,452
|
$257,726
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INST
|
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145 07040
|
$407,935
|
$61,190
|
Loud, Jennifer
|
DCEG (NCI)
|
|
|
Breast, Colorectal, and Ovary Cancer Clinical Validation Center
|
5U01CA152637-08
|
$1,085,901
|
$358,347
|
LI, CHRISTOPHER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$349,312
|
Restifo, Nicholas
|
CCR (NCI)
|
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-05
|
$562,579
|
$16,877
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-47
|
$3,572,644
|
$142,906
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Total relevant funding to Ovarian Cancer for this search: $120,788,374
|
